Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…